SD | Shutterstock
In research published in ACS’ Journal of Medicinal Chemistry, scientists created modified forms of psilocin, the active compound produced when psilocybin is processed in the body. In an early study involving mice, these new molecules maintained their biological activity while triggering fewer hallucinogenic-like effects than pharmaceutical grade psilocybin.